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We identified a  novel  T  cell Ag in the South African clawed toad  (Xenopus  laevis)  by  a  mAb  designated 281. This  Ag is  present 
in relatively high  levels  on most  thymocytes, approximately 65% of splenocytes, 55% of PBL, and 65% of intestinal  lympho- 
cytes, but is rarely seen on IgM+ B cells in any of these tissues. Lymphocytes bearing the 2B1 Ag proliferate in response to 
stimulation with Con  A  or  PHA,  whereas  the 281- lymphocytes are reactive  to LPS. Biochemical analysis  indicates  that  this  Ag 
is  a differentially phosphorylated glycoprotein of 71 to 82 kDa. The protein core of 64 kDa bears both N- and 0-linked 
carbohydrate side chains. The amino-terminal protein sequence of the 281 Ag shares significant homology with both the 
macrophage  scavenger receptor  type I motif and  the  mammalian CD5/CD6 family.  The  biochemical  characteristics  and cellular 
distribution of the 281 Ag suggest that it represents the CD5 homologue in X. laevis. While T cells constitutively express this 
highly conserved molecule, Xenopus 8 cells acquire the CD5 homologue only when they are stimulated in the presence of 
T cells. The journal of Immunology, 1995, 155: 421 8-4223. 
S ince  mammals  and  amphibians  shared  a  common  ancestor perhaps 350 million years ago, the comparative analyses of  their  immune  systems  is of considerable  phylogenetic 
interest. Among amphibian representatives, immune system pa- 
rameters have been characterized most extensively in the South 
African clawed frog, Xenopus fuevis (1, 2). These studies have 
shown  that  cellular  and  humoral  immunity  are  both  well  developed 
in Xenopus, and  the  Ig  genes  are  remarkably  similar  to  their  mam- 
malian counterparts in structural configuration and utilization (3, 
4). Xenopus is  also  the  only  ectothermic  species  in  which  the  clas- 
sical MHC class I and I1 genes,  as  well  as  non-MHC-linked  class 
I genes,  have  been  characterized (5, 6). 
X.  luevis is  an  especially  interesting  model  for  the  study  of T cell 
development because of the dramatic changes that occur during 
metamorphosis (7). These  frogs  are  also  one  of  the  rare  vertebrate 
species that can be easily and completely thymectomized very 
early in their ontogeny without otherwise affecting development 
(8). The  characterization of Xenopus T cells  is  limited,  however,  in 
part  because of a  paucity  of Xenopus cell  markers  that  would  allow 
T cell  identification  and  isolation. 
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Our studies define a T cell  Ag  in X .  laevis, the structural and 
functional  analysis of which  suggests  that  it  is  the  amphibian  ho- 
mologue of the CD5 lymphocyte differentiation Ag in mammals 
(9-13). In  contrast to its  constitutive  expression  by T cells, B cells 
acquire  this  putative CD5 homologue  after  stimulation  with Ph4A 
only  in  the  presence of T cells. 
Materials and  Methods 
Animals 
Larval  and  adult X. laevis were  purchased  from Xenopus I Inc.  (Ann  Arbor, 
MI) or  raised  in our laboratories. X. rropicalis, borealis, arnieri, ruwenzo- 
riensis, and  the LG15 clones (laevis X gilli hybrids) came  from  the  animal 
colony of the  Basel  Institute for Immunology (Basel, Switzerland). 
Thymectomy of 5-day-old  larvae was performed  as  described (8). 
Antibodies 
The murine mAb D8 (y3, K) recognizing X .  laevis IgM was produced in 
our laboratories (L. Gartland  and M. D. Cooper,  unpublished observations). 
The 2B1 mAb (yl, K) was produced by immunizing BAJ.,B/C mice with 
adult X. luevis splenocytes depleted  of D8+ cells (14). The F17 ( p , ~ )  and 
the AM22 ( p , ~ )  mAb, which are specific for frog CD8, have been de- 
scribed elsewhere (15, 16). The 2B1 mAb was purified from ascites by 
affinity  chromatography  and  conjugated  to  phycoerythrin by Southern  Bio- 
technology (Birmingham, AL). All secondary Abs were purchased from 
Southern Biotechnology. 
Cells 
The B3B7 thymoma  cell line was cultured at 27°C in a humidified  air-CO, 
atmosphere (4% CO,) as described (17). Fresh lymphocyte suspensions 
were prepared in amphibian PBS (65% mammalian PBS + 35% water) 
containing 10 U/ml  heparin (Elkins-Sinn, Cherry  Hill,  NJ). Single-cell SuS- 
pensions  were  obtained by teasing  thymus or spleen  through a steel  mesh, 
layered over a Ficoll-sodium ditrizoate density gradient (Pharmacia Bio- 
tech.,  Piscataway,  NJ)  and  then centrifuged at  room  temperature for 10 min 
at 200 X g. Cells recovered from the interphase layer were washed by 
centrifugation (three times) at 300 X g for 10 min at 4°C. Blood was 
obtained from the dorsal tarsus vein in adult anesthetized frogs with the 
addition of a heparin  solution (20 U/ml  in  amphibian  PBS)  to  avoid clotting 
(18), and lymphocytes (PBL) were enriched  as  described for splenocytes. 
Peritoneal cells were obtained from tadpoles by rinsing their peritoneal 
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cavity with amphibian PBS and subsequent centrifugation (18). Intraintes- 
tinal epithelial lymphocytes (lEL)4 were prepared according to the proce- 
dure of Coligan et al. (19). Briefly, the small intestine was rinsed exten- 
sively, transected, and cut into 1- to 2-cm pieces that were placed into a 
flask with an EDTA solution and stirred at 37°C for 30 min. The cell 
suspension was filtered through a nylon column and then layered on a 
Percoll gradient. Cells collected from the interphase were washed well 
before staining. Cell viability was determined by trypan blue exclusion. 
Mitogen activation and proliferation assays 
All assays were performed in equal amounts of AIM V medium, Leibovitz 
L15 medium, and tridistilled water, supplemented with sodium bicarbonate 
(final concentration 18 mmol/l; all reagents were from Life Technologies, 
Grand Island, NY) and 10% FCS (HyClone, Logan, UT) at 27°C in a 
humidified air-CO, (4%) atmosphere. For cell activation studies, spleno- 
cytes from adult frogs (5 to X mo old) were cultured in 24-well plates 
(Costar, Cambridge, MA) at 2.5 X 1O6/ml (1 mliwell) with or without 
PMA (SO ngiml; Sigma Chemical Co., St. Louis, MO). After 16 h, the 
PMA  was diluted by changing the medium. Proliferation assays were per- 
formed on negatively sorted splenocyte subpopulations. Specifically, 
splenocytes incubated with either the 2B1 mAb or the D8 mAb were 
washed, stained with hiotinylated goat-anti-mouse Ig, and washed again 
before incubation with MACS-streptavidin-microbeads (10 pl/107 cells; 
Miltenyi Biotec, Bergisch Gladbach,  Germany) for 15 min on ice. The  cells 
were washed again and stained with FITC-conjugated streptavidin. After a 
final wash in amphibian PBS containing  0.01% sodium azide, 5 mM EDTA 
and 1% BSA, cells were resuspended in SO0 pI of this buffer and applied 
to the top of a Mini-MACS separation column (Miltenyi Biotec) in a 
MACS separator (flow rate defined by a 23-gauge needle). The nonmag- 
netic fraction (purity >95% as judged by flow cytometry) was collected 
and washed three times in culture medium. Cells (2 X 10' well) were 
incubated for 72 h in 96-well flat-bottom plates (Costar) with either 5 
pgiml Con A, 1 pghl PHA (both from Sigma Chemical Co.) or 100 
pgiml LPS (S. typhimurum; Difco, Detroit, MI). ['HIThymidine (1 pCi; 
Amersham, Arlington Heights, IL) was added during the final 16 h of 
culture. Cells were collected using an automated cell harvester and counted 
by standard liquid scintillation; results obtained from triplicate cultures 
were expressed as mean counts per minute. 
lrnrnunofluorescence 
Indirect and direct immunofluorescence staining were employed for single- 
and two-color analysis. PMA-activated cells were incubated with normal 
goat serum before staining to minimize background staining. Cells (1 X 
lo6) were incubated with hybridoma supernatants of either the D8 mAb or 
an isotype-matched control mAb (20 min on ice), washed, and then reacted 
with FITC-conjugated goat-anti-mouse-y3  serum.  After washing, the cells 
were blocked with normal mouse serum and then stained with phyco- 
erythrin-conjugated 2B1 mAb. Relative immunofluorescence intensities of 
cells with lymphocyte light-scatter characteristics were determined by flow 
cytometry using a FACScan (Becton Dickinson, Mountain View, CA). 
Immunoprecipitation 
Cell surface proteins of 5 X lo7 cells (viability >95%) were labeled with 
1 mCi Na"'1 (Amersham) by the lactoperoxidase catalyzed method. After 
extensive washing, the cells were lysed in 150 mM NaCI, 50 mM Tris-HC1 
(pH 7.4), 5 mM EDTA, 0.1% NaN,, 1 mM pefabloc (Boehringer Mann- 
heim, Indianapolis, lN), 1 pgiml leupeptin, 1 pLgiml pepstatin A,  100 
pgiml chymostatin, 100 pgiml trypsininhibitor, 20 mM e-amino- 
n-caproic-acid, 2 pg/ml antipain, 2 pg/ml aprotinin, 20 mM iodoacetamide 
(all reagents were from Sigma Chemical Co.), and 0.5 or 1.0% Nonidet 
P-40  (Calbiochem, La Jolla, CA)  for 45 min at 4°C. Following centrifu- 
gation (100,000 X g, 45 min, 4"C), the lysate was subjected to immuno- 
precipitation by a solid-phase method (14), and absorbed molecules were 
eluted with 1 %  SDS in 50 mM Tris-HCI with or without 5% 2-ME. For 
dephosphorylation of '*'I-labeled molecules, immunoprecipitates in mi- 
crowells were incubated in reaction buffer  containing 4 U of calf intestinal 
alkaline phosphatase (Boehringer Mannheim) for 30 min  at 37°C (20). For 
glycolytic enzyme digestions, the immunoprecipitates were eluted with 
0.5% SDS and 0.1 M  2-ME  for 20 min at 80°C.  The reaction conditions 
were adjusted according to manufacturer's  suggestions  and the immuno- 
precipitates were incubated overnight at  37°C in the presence of 50 U/ml 
N-glycanase. After changing the pH to 6.3 with 1 M glacial acidic acid, the 
' Abbreviations used in this paper: IEL:  lntraintestinal epithelial lymphocytes; pl, 
isoelectric point. 
samples were incubated with 3 Uiml neuraminidase for 2 h at 37°C and 
then incubated overnight with 82 mU/ml 0-glycanase (all enzymes were 
from Genzyme, Boston, MA). Undigested controls  for each enzyme diges- 
tion were treated similarly but without the addition of enzymes. Samples 
were prepared for electrophoresis by addition of 6 X Laemmli sample 
buffer (21) containing  2-ME. "P-Labeling of the B3B7 cell line was per- 
formed essentially as described (22). Briefly, cells (S X 107i2 ml) were 
starved for 2 h in phosphate-free RPMI (Life Technologies) diluted 1:3 
with tridistilled water containing 2% BSA. After phosphate starvation, 1.25 
mCi/ml [32P]orthophosphate (HCI free; Amersham) was added and the 
cultures were incubated for 3 h  at 27°C. Cells were then washed and in- 
cubated in 1% Nonidet P-40 lysis buffer, containing protease inhibitors and 
phosphatase inhibitors (0.1 mM  Na,VO,, 0.4 mM EDTA, 10 mM 
Na,P,O,, 10 mM NaF, 0.1% NaN,). Immunoprecipitates were electropho- 
resed on 7.5% linear or S to 15% gradient SDS-PAGE as described (21). 
pended in 9.5 M urea, 2% Nonidet P-40.2% ampholites (pH 3.5 to lo), and 
For two-dimensional gel analysis, the immunoprecipitates were resus- 
jected to a 5 to 15% gradient SDS-PAGE  as described (23). 
5% 2-ME; separated in a tube gel containing ampholites; and then sub- 
Protein purification 
Cell lysates from IO"' B3B7 thymoma cells (1 X 10' cells/ml lysis buffer) 
were obtained as described above. After preclearing twice on Sepharose 
beads coupled  to mAb of irrelevant specificity, the lysate was incubated 
with 2B1 coupled Sepharose beads (8 mg mAb/ml beads). Following ex- 
tensive washing, the 2B1 Ag was eluted with 0.2 M glacial acetic acid and 
the fractions containing protein were combined, evaporated under vacuum, 
redissolved in Laemmli sample buffer, and separated on a 7% SDS-PAGE. 
Proteins were electroblotted and visualized by Coomassie blue staining. 
Bands corresponding to the M ,  range of the 2B1 Ag were excised and 
subjected to protein sequencing. 
Results 
Tissue distribution and ontogeny o f  28 7 + cells 
Immunofluorescence analysis of lymphoid tissues from young 
frogs revealed that the 2B1 Ag is expressed on the vast majority of 
thymocytes (85% -+ 3.5; mean -t SD, n = 3), and at relatively high 
levels on 63% -t 4.1 (n  = 6 )  of the splenocytes, 52% ? 3.6 (n = 
6 )  of PBL, and 65% 2 4.7 (n = 6 )  of the IEL (Fig. 1A). The IgM- 
B3B7 thymoma cell line expressed high levels of the 2B1 Ag (data 
not shown). The IgMt B cell population constituted approxi- 
mately 30%, 20% and 10% of the lymphocytes in spleen, blood, 
and intestine, respectively, and these rarely expressed the 2B1 Ag 
at higher than background levels. B cells in the peritoneal fluid of 
tadpoles were also examined with the same result (Fig. I B ) .  
As early as the 17th day of larval life, almost 90% of the thy- 
mocytes were found to express the 2B1 Ag, and this level of 2B1 
expression was maintained beyond metamorphosis. In contrast, the 
frequency of 2B1+ cells in the spleen gradually increased from 
approximately 20% of the splenocytes in 17-day-old larvae to 
reach adult levels of approximately 65% in 90-day-old frogs (Fig. 
2). All  of the CD8+ cells in the spleen, blood, and IEL populations 
expressed the 2B1 Ag at relatively high levels irrespective of 
donor age. 
Species specificity o f  the 28 I epitope 
Spleen cells from five other Xenopus species were examined for 
reactivity with the 2B1 mAb. Cells from X. tropicalis, borealis, 
amieti, and ruwenzoriensis were nonreactive, whereas spIeen cells 
from LG15 frogs (laevis X gilli hybrid) expressed the 2B1 Ag at 
the same intensity and in the same frequency as X. laevis. This 
result suggests that X. gilli T cells also express the 2B1 epitope 
expressed by X. laevis T  cells and is in agreement with evidence 
suggesting that these are closely related Xenopus species (24). 
Biochemical characterization of the 2 B  1 reactive molecule 
When the 2B1 Ag on B3B7 thymic tumor cells  was analyzed by 
SDS-PAGE,  a single major band with the apparent M ,  of 71 kDa 
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FIGURE 1. Distribution of 261+ cells in lymphoid tissues. Viable 
thymocytes, IEL, splenocytes, and PBL from adult  frogs ( A )  or perito- 
neal cells from tadpoles ( B )  were  analyzed by two-color  immunoflu- 
orescence for 2B1 and IgM expression. Note  that  lgMt  lymphocytes in 
all of these  tissue  sites do not express 261 Ag at  high  levels, and few 
express  even  low  levels of Ag. 
was observed under nonreducing conditions, and an 82-kDa pro- 
tein under reducing conditions (Fig. 3A). In most experiments, a 
faint band of approximately 170 kDa was also detected, suggesting 
a tendency to dimerize under these experimental conditions. Sim- 
ilar results were obtained when the 2B1 Ag was examined on 
splenocytes from adult frogs (data not shown). In two-dimensional 
gels, the 2B1 Ag migrated as  a broad band with an isoelectric point 
(PI) range of 5.2 to 6.0 (Fig. 4). To determine the relative M, of the 
protein core of this cell surface Ag, the 2B1 immunoprecipitates 
were digested with glycolytic enzymes. Treatment with neuramin- 
idase and 0-glycanase yielded a protein band of 78 kDa under 
reducing conditions (Fig. 3 B ) .  After N-glycanase treatment, two 
protein bands of 71 and 67 kDa were observed. Digestion with all 
three enzymes resulted in the appearance of discrete bands of 71 
and 64 kDa (Fig. 3B).  
When B3B7 thymic tumor cells were metabolically labeled with 
["P]orthophosphate, a single 2B1 reactive molecule of approxi- 
mately 82 kDa was detected under reducing conditions (Fig. 3C). 
To further elucidate the nature of the two proteins observed after 
deglycosylation, the 2B1 immunoprecipitates were treated with 
phosphatase  before  digestion  with  the glycolytic enzymes and a single 
band  of 64 kDa was detected  under  these conditions (Fig. 30). 
2B1 amino-terminal  protein sequence is homologous to 
mammalian CD5 sequences 
To further characterize the 2B1  Ag, it was purified from lysates of 
B3B7 cells by affinity chromatography. Following SDS-PAGE 
separation, two protein bands migrating in the 2B1 M, range were 
visualized by Western blot analysis, which presumably represented 
the phosphorylated and nonphosphorylated forms. Identical 25 res- 
idue amino acid sequences were obtained for both bands. When 
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FIGURE 2. Ontogeny of 261 Ag expression by thymocytes  and 
splenocytes. Lymphocytes of larvae, tadpoles, and young frogs were 
isolated  and  stained  for  cell  surface 261 expression. Early points rep- 
resent values for pooled samples from at least 10 animals, whereas 
individual values (mean ? SD) were determined for larger animals. 
Metamorphosis occurred between 65 and 90 days. 
this amino-terminal sequence was compared with the known mam- 
malian CD5 sequences, 10 of 25 residues were shared, including 
four amino acids that are conserved in all mammalian CD5 pro- 
teins (Fig. 5). Alignment of homologous sequences suggested that 
the amino terminus of the 2B1 Ag is slightly shorter than the 
mammalian CD5 counterparts. Analysis of the amino-terminal 
2B1 sequence also revealed significant homology with the macro- 
phage scavenger receptor type I motif (Fig. 5,  top line), multiple 
repeats of which characterize the family of cell surface molecules 
to which CD5 belongs (25). 
Mitogen responsive patterns of the 2 B I +  and IgM+ 
splenocytes 
Magnetic cell separation was employed to isolate the 2B1- and 
IgM- subpopulations of splenic lymphocytes for functional anal- 
ysis. This negative isolation strategy was employed because it  
yields relatively pure populations of viable IgMt and 2Bl t  (95% 
purity) cells without deliberate stimulation during the isolating 
procedure. In the presence of Con A or PHA, the IgM- cells 
showed vigorous proliferative responses, whereas the 2B1- were 
relatively unresponsive to these classical T cell mitogens (Fig. 6). 
In contrast, the 2B1-  cells could be stimulated by LPS, whereas 
the IgM- cells were unresponsive. These results confirm the T cell 
nature of the 2Blt  cells. 
B cells  can express the 2B1 Ag when stimulated with PMA 
in the presence of T cells 
When expression of the 2B1 Ag was examined following PMA 
stimulation of splenocytes, the IgM+ cells began to express the 
2B1 Ag as early as 4  h after PMA stimulation, at first  in relatively 
low levels that increased over a 40-h period of PMA stimulation 
(Fig. 7A). Even at maximal levels, however, the density of the 2B1 
Ag on activated B  cells was consistently lower than on resting T 
cells, which acquired even higher 2B1 levels following PMA ac- 
tivation. At the same time that B cells acquired cell surface 2B1 
Ag, their IgM Ag receptors were down-modulated by PMA stim- 
ulation, presumably as  a consequence of protein kinase C-induced 
phosphorylation and internalization of the B cell receptor complex 
(26). These dramatic effects of PMA activation were observed 
when Xenopus B cells were stimulated in the presence of T cells 
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FIGURE 3. Biochemical analysis of the 2B1 Ag. B3B7 thymic tumor cells were surface iodinated (A, B, and D) or metabolically labeled with 
["Plorthophosphate (C) ,  and cell lysates incubated with either isotype-matched control mAb (Co) or 2B1 mAb. After the indicated enzyme 
treatments, immunoDreciDitates were analvzed bv  SDS-PACE on a  5 to 15% (A, 6, and D) or a 7.5% gel under nonreducing (NR; A )  or reducing 
(R; A-D) conditions. The M, (X10') of protein standards is indicated. 
. .  






FIGURE 4. Two-dimensional gel analysis of the 2B1 Ag. 2B1 immu- 
noprecipitates were separated first  by isoelectric  focusing and then by 
electrophoresis on a 5 to 15% SDS-PACE.  pl and M,  ( X 1 0 ' )  of protein 
standards is indicated. 
and other cell types in the normal spleen. To determine the pos- 
sible effects of T cells  on the B cell activation response, spleno- 
cytes were tested from frogs that were thymectomized as 5-day-old 
larvae. While B cells in  these T cell-deficient splenocytes re- 
sponded normally to PMA  stimulation with regard to down-mod- 
ulation of their cell surface IgM, they failed to express the 2B1 Ag 
by I6 h (Fig. 7B) or after 40 h  (data not shown) of PMA treatment. 
Discussion 
The Xenopus 2B1 Ag  appears to have all of the essential charac- 
teristics expected for an amphibian CD5 homologue. Mammalian 
CD5 was initially characterized as  a  pan-T cell Ag that serves as 
a thymocyte differentiation marker (9-13, 27). With further  study, 
i t  became evident that a distinct B cell subpopulation in humans 
and mice may also  express CD5 (28), and recently the CD72 mol- 
ecule present on all human B cells has been identified as a CD5 
ligand (29). CDS+ B cells  are relatively abundant in the peritoneal 
cavity, have remarkable self-renewal capacity, and are considered 
potential mediators of autoimmune  diseases  on the basis of their 
production of polyreactive Abs (28). Interestingly, however, all of 
the B cells in rabbits are CD5+ (30), whereas CD5 is absent on rat 
B cells (31). Structurally, the CD5 Ag belongs to a newly defined 
family characterized by the macrophage scavenger type I motif, 
which  includes the CD6 Ag and the WCl Ag  found  on ruminant 
y6 T cells (25, 32, 33). In spite of their relatively extensive 
characterization, the function of  these molecules is still largely 
unknown. 
The Xenopus 2B1 molecule is expressed  on virtually all thymo- 
cytes from early larval stages onward, and thus, like mammalian 
CD5 (34). is an early thymic differentiation Ag. In peripheral tis- 
sues,  lymphocytes  belonging to the IgM- lymphocyte population 
express the 2B1+ Ag in relatively high levels. The 2B1+ popula- 
tion includes both CD8+ and CD8- lymphocytes, thus suggesting 
that both cytotoxic and helper T cells  express the 2B1 Ag. 
To test the idea that the 2B1 Ag is a pan-T cell marker in Xe- 
nopus, we examined  the response of lymphocyte subpopulations to 
classical T o r  B cell mitogens. When enriched by removal of IgM+ 
splenocytes, the 2B1+ cells proliferated well in response to clas- 
sical T cell mitogens, Con A and PI", but were unresponsive to 
the B cell mitogen LPS. In contrast, Xenopus B cells, enriched by 
removal of the 2B1+ cells, responded with proliferation to LPS 
stimulation but were unresponsive to Con A and PHA. These re- 
sults  further attest to the T cell nature of the IgM- population of 
Xenopus 2B1+ lymphocytes. 
In ontogenetic  studies,  thymocyte  expression of the 2B1 Ag was 
consistently high at all ages, whereas the frequency of 2B1+ cells 
in the spleen increased steadily from approximately 20% in  17- 
day-old tadpoles to reach adult levels of approximately 65% 
around the time of metamorphosis. The immune  system repertoire 
of X .  Iuevis has to be reshaped during  metamorphosis to accom- 
modate novel self and environmental Ag. This is accomplished by, 
as yet, poorly understood mechanisms that temporarily render pe- 
ripheral T cells  unresponsive to stimulation. In addition, an adult 
population of T cells is generated via a new wave of progenitor 
cells  entering the thymus  during  metamorphosis (35). Although the 
total number of T cells in both thymus and spleen  declines  during 
metamorphosis (l), our findings, together with more detailed ob- 
servations of thymocytes and splenocytes  during the metamorphic 
period, indicate that the relative frequency of 2B1+ cells  remains 
unaffected, perhaps reflecting the gradual replacement of larval T 
cells by newly formed adult lymphocytes. 
Stimulation of mammalian B cells with the protein kinase C 
activator PMA leads to CD5 expression (36,  37). When Xenopus 
splenocytes  were activated with PMA, IgM+ B lymphocytes were 
also induced to express the 2B1 Ag,  albeit at lower levels than  on 
T cells, while down-modulating their cell surface IgM. Interest- 
ingly, PMA-activated B cells from athymic frogs exhibited IgM 
down-modulation, but they did not express  the 2B1 Ag. This sug- 
gests that Xenopus B cells require T cell influences to express the 
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Macrophage Scavenger 
Receptor Type  I Motif a-R-L-a-.-G-p-.-.-C-p-G-p-V-E-a-.-. * 
Xenopus N-K-A-@-P-V-S  G-A-K~P-P[E[A 
Mouse Q-S-G-R-G-G-L-D-I-Q 
Rat 
Human R-L-S-W-YBP-D-F-Q T-R-S N S-K C Q G Q 
Bovine G-L-K-V-E-V-Q-G-L-T S-G-S-G-S-R C Q G R- 
S-G-S S-K C Q G Q 
S-G-S N S-K C Q  G  L E-K-G-R-G-F-V-G-A-Q 
FIGURE 5. 2B1 amino-terminal sequence is homologous to mammalian CD5 and macrophage scavenger receptor type I motif. Twenty-five 
amino acids obtained by peptide sequencing of 251 immunoprecipitates were aligned to macrophage  scavenger  receptor  type 1 motif (Ref. 25) 
and  CD5 sequences of mouse (39), rat (31 ), human (40), and  bovine (41). Gaps (slash) are introduced  to  maximize  homology  and  periods (period) 
denote nonconserved amino acids. a, Aliphatic  residue, p = polar  residue; *, Cysteine,  only  present in CD5/CD6  subfamily. 
I 2B1- 
I g M  
PMA treated: 
IgM - FIGURE 6. Mitogen  responsiveness of  IgM- and  2B1-  splenocytes. 251 or IgM depleted populations were obtained by negative magnetic sorting.  After  staining  with  respective mAb and  cell  separation  on a mini- MACS column  as  described in Materials andMethods, splenocytes (2 X 105/well)  were  incubated in triplicate  with  mitogens  indicated.  Prolifera- 
tion was measured in cpm after 72 h in culture by [3Hlthymidine incor- 
poration  and  expressed  as  mean t SD  (minus  background). 
A. Splenocytes from Normal Donor 
2B1 Ag  following activation. The selective acquisition of the 2B1 
Ag by B  cells activated together with T cells, other T cell Ag not 
being acquired, suggests that the activated B  cells make their own 
2B1 Ag. However, we have not  yet performed a biosynthetic anal- 
ysis of the activated B  cells to test this assumption. 
Biochemical  characterization of the  2B1 Ag  indicates that it 
is  a  single-chain  transmembrane  glycoprotein of approximately 
71 kDa  under nonreducing  conditions. The  native  molecule  has 
a considerable charge heterogeneity reflected by its isoelectric 
distribution  from PI 5.2 to 6.0. The M ,  of mammalian CD5  Ag 
are reported to be 62  to 72 kDa and also exhibit considerable 
charge heterogeneity (9-13). 
The higher M, observed after reduction of the 2B1 molecule (82 
kDa) probably reflects the presence of intramolecular disulfide 
bonds. Another important characteristic of CDS is constitutive 
phosphorylation (38), which was also demonstrated for the 2B1 
Ag. In our experiments, glycosidase treatment of the  2B1 Ag re- 
sulted in the appearance of two distinct bands of approximately 71 
and 64 kDa. Treatment of the deglycosylated proteins with phos- 
phatase revealed that the 71-kDa protein was the phosphorylated 
form of the 64-kDa band. Thus, after removal of carbohydrates and 
dephosphorylation, the protein core size of the 2B1 determinant is 
approximately 64 kDa. An abundance of N-linked sugars appar- 
ently accounts for approximately 18 kDa  of the  mature glycoprotein, 
as is the case for the  mouse  and  human CD5 molecules (39, 40). 
Since mammalian CD5 and CD6 comprise a subfamily of the 
molecules containing the macrophage scavenger motif, we have 
considered the possibility that the Xenopus lymphocyte-specific 
2B1  Ag could be a  CD6 homologue rather than a  CD5 homologue. 
However, several characteristics suggest that the 2B1 Ag more 
6. Splenocytes from Thymectomized Donor 
IgM 
FIGURE 7. B cells can express 261 Ag after PMA stimulation in the 
presence of T cells. Splenocytes (2.5 X 1Ob/rnl) from  normal adult frogs 
( A )  or thymectomized frogs (6) were incubated with 50 ng/ml PMA 
(PMA treated) or  with  media (Control) and  then  analyzed  for  281 (PE) 
and IgM (FITC) cell surface  expression  as a function of time. 
closely resembles mammalian CD5. 1) The  2B1 expression pattern 
for Xenopus thymocytes is very characteristic for mammalian 
CD5, whereas CD6 is found only in low density on a subpopula- 
tion of mammalian thymocytes (42). 2) While the M ,  of 2Bl is 
very close to that of mammalian CDS, it is quite different from that 
of mammalian CD6, which is 130 kDa (43). 3) CD6 has not been 
found on activated B cells. While the sequence comparison of the 
N-terminal amino acids of 2B1 cannot discriminate between mam- 
malian CD5 and CD6 relationships, current efforts to clone the 
2B1  gene could formally resolve this issue. Interestingly, the  2B1 
N-terminal sequence lacks two serines and a glutamine that are 
present in mammalian CD5 sequences. While this difference is not 
surprising given the great phylogenetic  distance  between amphibians 
and mammalians, it should be informative in determining the most 
highly  conserved elements of these  lymphocyte-specific  proteins. 
In conclusion, our analysis of tissue distribution, biochemical 
properties, protein sequence, and functional studies suggest that 
The Journal of Immunology 4223 
the 2B1 molecule represents the homologue of the CD5 Ag. The 
2B1 mAb that recognizes this Xenopus CD5 candidate also serves 
as  a pan-T cell marker that can be used to study development of the 
Xenopus immune system. As in mammals, Xenopus B cells can 
also express this CD5 homologue provided that they are activated 
in the presence of T cells. The remarkable conservation of this 
molecule over 350 million years points to its functional impor- 
tance, the precise nature of which remains unknown. 
Acknowledgments 
The authors  thank Dr. Chen-lo Chen for critical comments and suggestions, 





















Du Pasquier, L., J. Schwager, and M. F. Flajnik. 1989. The immune system of 
Xenopus. Ann. Rev. Immunol. 7:251. 
Du Pasquier, L. 1993. Evolution of the immune system. In Fundamental Immu- 
nology, 3rd ed. W. E. Paul, ed. Raven Press, New York, p. 199. 
Du Pasquier, L. 1993. Phylogeny of B a l l  development. Curr.  Opin. Immunol. 
5: 185. 
Schwager, J., N. Biirckert, M. Schwager, and M. Wilson. 1991. Evolution of 
contribution to antibody diversity. EMBO J. 1U:SOS. 
immunoglobulin light chain genes: analysis of Xenopus IgL isotypes and their 
of frogs. Immunol. Rev. 113r47. 
Flajnik, M. F.,  and  L.  Du Pasquier. 1990. The major histocompatibility complex 
Flajnik, M. F., M. Kasahara, B.  P. Shum, L. Salter-Cid, E. Taylor, and 
L. Du Pasquier. 1993. A novel type of class I gene organization in vertebrates: a 
large family of non-MHC-linked class I genes is expressed at the RNA level in 
the amphibian Xenopus. EMBO J. 12:4385. 
Flajnik, M. F., E. Hsu, J. F. Kaufmann, and L. Du Pasquier. 1987. Changes in  the 
immune system during metamorphosis of Xenopus. Immunol. Today 8:58. 
Du Pasquier, L.,  and J. D. Horton. 1976. The effect of thymectomy on the mixed 
leukocyte reaction and phytohemagglutinin responsiveness in the clawed toad 
Xenopus  Iaevis.  Immunogenetics 31105. 
Reinherz, E. L.,  P.  C. Kung, G .  Goldstein, and S. F. Schlossman. 1979. A mono- 
clonal antibody with selective reactivity with functionally mature human thymo- 
cytes and all peripheral human T cells. J. Immunol. 123:1312. 
Cantor, H., and E. A. Boyse. 1975. Functional subclasses of T lymphocytes 
bearing different Ly antigens. 1. The generation of functionally distinct T-cell 
subclasses is a differentiative process independent of antigen. J. Exp. Med. 141: 
1376. 
Mackay, C. R., J. F. Maddox, K. J. Gogolin-Ewens, and M. R. Brandon. 1985. 
Characterization of two sheep lymphocyte differentiation antigens, SBU-TI and 
SBU-T6. Immunology 55:729. 
Ackley, C. D., and M. D. Cooper. 1992. Characterization of a feline T-cell- 
53:466. 
specific monoclonal antibody reactive with a CD5-like molecule. Am. J. Vet.  Res. 
clonal antibody labels rat T lymphocytes and augments in vitro proliferate re- 
Dallman, M. J., M. L. Thomas, and J .  R. Green. 1984. MRC OX-19: a mono- 
sponses. Eur. J. Immunol. 14:260. 
Chen, C.-L. H., T. C. Chanh, and M. D. Cooper. 1984. Chicken thymocyte- 
specific antigen identified by monoclonal antibodies: ontogeny, tissue distribution 
and biochemical characterization. Eur. J. Immunol. 14.385. 
and  M.  D. Cooper. 1991. Analysis of T cell development in Xenopus.  Fed.  Proc. 
Ibrahim, B., L. A. Gartland, T. Kishimoto, R. Dzialo, H. Kubagawa, R.  P. Bucy, 
5:765l. 
Flajnik, M. F., S. Ferrone, N. Cohen, and  L.  Du Pasquier. 1990. Evolution of the 
molecules. Mol. Immunol. 27:451. 
MHC: antigenicity and unusual tissue distribution of Xenopus (frog) class I1 
Du Pasquier, L., and J. Robert. 1992. In vitro growth of thymic tumor cell lines 
from Xenopus.  Dev. Immunol. 2:29S. 
Du Pasquier, L., M. F. Flajnik, C. Guiet, and E. Hsu. 1985. Methods used to study 
the immune system of Xenopus (Amphibia, Anura). In Immunological Methods, 
Vol. 3. I. Lefiovits, B. Pernis, eds. Academic Press, New York, p. 425. 
19. Coligan, J., A. M. Kruisbeck, D. H. Margulies, E. M. Shevach, and W. Strober, 
eds. 1991. Current Protocols in Immunologv. 1. Wiley & Sons, New  York, Sec- 
tion 3.19. 
20. Da Silva, A. J., and C. E. Rudd. 1993. A 72-kilodalton fyn-related polypeptide 
(~72'Y"-~) binds to the antigen-receptor/CD3 (TcWCD3) complex. J. Bid. Chem. 
268:16537. 
21. Laemmli. U. K. 1970. Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature 256.495. 
22. Testi, R., J. H. Phillips, and L. L. Lanier. 1988. Constitutive expression of a 
phosphorylated activation antigen (LEU 23) by CD3h''"h' human thymocytes. 
J. Immunol. 141r2557. 
23. O'Farrell, P. H. 1975 High resolution two-dimensional electrophoresis of pro- 
teins. J. Biol. Chem. 250:4007. 
24. Kobel, H.  R.,  and L. Du Pasquier. 1975. Production of large clones of histocom- 
patible, fully identical clawed toads (Xenopus). Immunogenetics 2:87. 
25.  Freeman, M., J. Ashkenas, D. J.  G. Rees, D.  M. Kingsley, N. G. Copeland, N. A. 
Jenkins, and  M. Krieger. 1990. An ancient highly conserved family of cysteine- 
rich domains revealed by cloning type I and I1 murine macrophage scavenger 
receptors. Proc. Natl. Acad. Sci. USA 8727810. 
26. Miller, R. A,, and J. Gralow. 1984. The induction of LEU-I antigen expression 
J. Immunol. 133:3408. 
in human malignant and normal B cells by phorbol myristic acetate (PMA). 
27. Mathieson, B. J., S. 0. Sharrow, Y. Rosenberg, and U. Hammerling. 1981. Lyt 
lf23- cells appear in the thymus before Lyt 123+ cells. Nature 289:17Y. 
28. Kipps, T. 1989. The CD5 B cell. Adv. Immunol. 47:117. 
7.9. Van de Velde, H., I .  von Hoegen, W. Luo, J. R. Parnes, and  K. Thielemans. l Y Y l .  
The B-cell surface protein CD7Z/Lyb-2 is the ligand for CD5. Nature 35lt662. 
30. Raman, C., and K. L. Knight. 1992. CD5+ B cells predominate in  peripheral 
tissues of rabbit. J. Immunol. 149:385X. 
31. Vermeer, L. A,, N. K. de Boer, C. Bucci, N. A. Bas, F. G. M. Kroese, and 
S. Alberti. 1994. MRC OX19 recognizes the rat CDS surface glycoprotein, but 
does not provide evidence for a population of CDSbrmgh' B cells. Eur: J. Immunol. 
241585. 
32. Wijngaard, P. L. J. ,  M. J. Metzelaar, N. D. MacHugh, W. I. Morrison, and H. C. 
Clevers. 1992. Molecular characterization of the WCI antigen expressed specif- 
ically on bovine CD4KCD8- T lymphocytes. J. Immunol. 14913273. 
33. Aruffo A,, M. 8. Melnick, P. S. Linsley, and B. Seed. 1991. The lymphocyte 
glycoprotein CD6 contains a repeated domain structure characteristic of a new 
family of cell surface and secreted proteins. J.  Exp. Med. 174r949. 
34. Spits, H. 1994. Early stages in human and mouse T-cell development. Curr. @in. 
Immunol. 6:212. 
35. Turpen, J. ,  and P. E. Smith. 1989. Precursor immigration and thymocyte succes- 
sion during larval development and metamorphosis in Xenopus. J. Immunol. 142: 
41. 
36. Freedman, A. S. ,  A. W. Boyd, F. R. Bieber, J. Daley, K. Rosen, J. C. Horowitz, 
D. Levy, and  L.  M. Nadler. 1987. Normal cellular counterparts of B cell chronic 
lymphocytic leukemia. Blood 70:418. 
37. Freedman, A. S., G. Freeman, J. Whitman, J .  Segil, J. Daley, H. Levine, and 
L. M. Nadler. 1989. Expression and regulation of CD5 on in vitro activated 
human B cells. Eur. J. Immunol. 19.349. 
38. Chatila, T. A., and R. S. Geha. 1988. Phosphorylation of T cell membrane pro- 
teins by activators of protein kinase C. J. Immunol. 140:4308. 
39. Huang, H.-J. S . ,  N. H. Jones, J. L. Strominger, and L. A. Herzenberg. lY87. 
Molecular cloning of Ly-I,  a membrane glycoprotein of mouse T lymphocytes 
and a subset of B cells: molecular homology to its human counterpart Leu-l,Tl 
(CD5). Proc. Natl. Acad. Sci. USA X4:204. 
40. Jones, N. H.,  M. L Clabby, D. P .  Dialynas, H.-J. S .  Huang, L. A. Herzenberg, and 
1. L. Strominger. 1986. Isolation of complementary DNA clones encoding the 
human lymphocyte glycoprotein TliLeu-I. Nature 323:346. 
41. Yu, Q., M. Reichert, T. Brousseau, Y. Cleuter, A. Burny, and R. Kettman. 1990. 
Sequence of bovine CD5. Nucleic Acid.< Res. 18:52Y6. 
42. Morimoto, C., C. E. Rudd, N. L. Letvin, M. Hagan, and S. F. Schlosaman. IY8X. 
ZHI-A novel antigen involved in T lymphocyte triggering. J. Immunol. 140: 
2/65, 
43. Swack, J .  A., J. W. Mier, P.  L. Romain, S .  R. Hull, and C. E. Rudd. 1Y91. 
ducing molecule. J. Biol. Chem. 266:7137. 
Biosynthesis and post-translational modification of CDh, a T cell sign;rl-trans- 
